In the last trading session, 6.81 million Akero Therapeutics Inc (NASDAQ:AKRO) shares changed hands as the company’s beta touched -0.27. With the company’s per share price at $47.57 changed hands at $9.43 or 24.72% during last session, the market valuation stood at $3.79B. AKRO’s last price was a discount, traded about -22.77% off its 52-week high of $58.40. The share price had its 52-week low at $17.86, which suggests the last value was 62.46% up since then.
Analysts gave the Akero Therapeutics Inc (AKRO) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 4 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended AKRO as a Hold, 4 felt it is a Buy and 0 rated the stock as Underweight.
Akero Therapeutics Inc (NASDAQ:AKRO) trade information
Instantly AKRO was in green as seen at the end of in last trading. With action 18.90%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 70.99%, with the 5-day performance at 18.90% in the green. However, in the 30-day time frame, Akero Therapeutics Inc (NASDAQ:AKRO) is 26.28% up.
The consensus price target for the stock as assigned by Wall Street analysts is 45, meaning bulls need a downside of -5.71% from its current market value. According to analyst projections, AKRO’s forecast low is 38 with 56 as the target high. To hit the forecast high, the stock’s price needs a -17.72% plunge from its current level, while the stock would need to tank 20.12% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -5.28%. The 2025 estimates are for Akero Therapeutics Inc earnings to decrease by -3.81%, but the outlook for the next 5-year period is at -8.83% per year.
AKRO Dividends
Akero Therapeutics Inc is expected to release its next quarterly earnings report in June.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 8.0778% or 5.59 million shares worth $131.06 million as of 2024-06-30.
